Macter expands Cobolmin range with sublingual option

MG News | December 22, 2025 at 03:55 PM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

December 22, 2025 (MLN): Macter International Limited (PSX: MACTER) introduced Cobolmin SL, a sublingual formulation of Mecobalamin.

The company stated that Cobolmin SL offers rapid absorption and enhanced convenience for patients through sublingual administration, the company’s filing on PSX revealed today.

The product expands the existing Cobolmin range, which includes tablets and injections, and underscores Macter International’s focus on innovation in healthcare.

At the time of writing, MACTER shares were trading at Rs 337.59, up 2.51 points, or 0.75%.

Copyright Mettis Link News

Related News

MTL earnings forecasts raised up to 45% on strong margins

PSX Closing Bell: Bull Power

PSX Mid-Day: Above and Beyond 180K

Name	Price/Vol	%Chg/NChg
KSE100	180,392.98 610.92M	1.89% 3353.15
ALLSHR	108,164.81 1,218.64M	1.62% 1725.65
KSE30	53,921.42 273.38M	1.95% 1030.99
KMI30	256,900.46 245.46M	1.35% 3425.80
KMIALLSHR	69,949.43 735.02M	1.15% 794.76
BKTi	49,914.69 75.35M	3.58% 1722.97
OGTi	36,322.92 15.57M	1.25% 446.83

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	65,645.00	67,010.00 65,360.00	-930.00 -1.40%
BRENT CRUDE	79.71	83.80 78.45	-3.46 -4.16%
RICHARDS BAY COAL MONTHLY	123.00	0.00 0.00	5.25 4.46%
ROTTERDAM COAL MONTHLY	125.50	125.50 125.00	-0.45 -0.36%
USD RBD PALM OLEIN	1,157.50	1,157.50 1,157.50	0.00 0.00%
CRUDE OIL - WTI	76.90	81.58 75.52	-3.85 -4.77%
SUGAR #11 WORLD	14.29	14.35 14.04	0.10 0.70%